{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T14:57:37Z","timestamp":1778770657613,"version":"3.51.4"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ejogrb.2025.114682","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T06:10:18Z","timestamp":1756707018000},"page":"114682","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A retrospective comparison of live birth rate in freeze-all cycles between progestin-primed ovarian stimulation with dydrogesterone and GnRH antagonist protocols"],"prefix":"10.1016","volume":"314","author":[{"given":"Tien Khac","family":"Le","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toan Duong","family":"Pham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuyen Thi-Ha","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nguyen-Tuong","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho Long","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuong Manh","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan Ngoc","family":"Vuong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2025.114682_b0005","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1093\/humrep\/dew051","article-title":"Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF\/ICSI cycles","volume":"31","author":"Toftager","year":"2016","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2025.114682_b0010","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1056\/NEJMoa1703768","article-title":"IVF transfer of fresh or frozen embryos in women without polycystic ovaries","volume":"378","author":"Vuong","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2025.114682_b0015","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.rbmo.2014.02.003","article-title":"Novel aspects of the endocrinology of the menstrual cycle","volume":"28","author":"Messinis","year":"2014","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ejogrb.2025.114682_b0020","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1210\/endo-109-4-1293","article-title":"On the site of action of progesterone in the blockade of the estradiol-induced gonadotropin discharge in the rhesus monkey","volume":"109","author":"Wildt","year":"1981","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejogrb.2025.114682_b0025","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.fertnstert.2015.03.022","article-title":"Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization","volume":"104","author":"Kuang","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2025.114682_b0030","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1093\/humrep\/deab093","article-title":"Micronized progesterone plus dydrogesterone versus micronized progesterone alone for luteal phase support in frozen-thawed cycles (MIDRONE): a prospective cohort study","volume":"36","author":"Vuong","year":"2021","journal-title":"Human Reprod"},{"key":"10.1016\/j.ejogrb.2025.114682_b0105","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/09513590.2015.1121982","article-title":"Dydrogesterone use in early pregnancy","volume":"32","author":"Mirza","year":"2016","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ejogrb.2025.114682_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2017.06.017","article-title":"Duphaston and human menopausal gonadotropin protocol in normally ovulatory women undergoing controlled ovarian hyperstimulation during in vitro fertilization\/intracytoplasmic sperm injection treatments in combination with embryo cryopreservation","volume":"108","author":"Zhu","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2025.114682_b0040","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.2147\/DDDT.S230129","article-title":"Progestin-primed ovarian stimulation with dydrogesterone versus medroxyprogesterone acetate in women with polycystic ovarian syndrome for in vitro fertilization: a retrospective cohort study","volume":"13","author":"Huang","year":"2020","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.ejogrb.2025.114682_b0045","article-title":"Comparison of dydrogesterone and medroxyprogesterone in the progestin-primed ovarian stimulation protocol for patients with poor ovarian response","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.ejogrb.2025.114682_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.rbmo.2023.103639","article-title":"Progestin-primed ovarian stimulation: for whom, when and how?","volume":"48","author":"Ata","year":"2024","journal-title":"Reprod BioMed Online"},{"key":"10.1016\/j.ejogrb.2025.114682_b0055","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/ijgo.14903","article-title":"Outcomes and cost-effectiveness comparisons of progestin-primed ovarian stimulation, GnRH antagonist protocol, and luteal phase stimulation for fertility preservation","volume":"163","author":"Zhao","year":"2023","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ejogrb.2025.114682_b0060","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.rbmo.2013.07.008","article-title":"Anti-M\u00fcllerian hormone versus antral follicle count for defining the starting dose of FSH","volume":"27","author":"Lan","year":"2013","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ejogrb.2025.114682_b0065","doi-asserted-by":"crossref","unstructured":"Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology. The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting. Hum Reprod 2011;26:1270\u201383.","DOI":"10.1093\/humrep\/der037"},{"key":"10.1016\/j.ejogrb.2025.114682_b0070","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.fertnstert.2024.01.027","article-title":"A randomized controlled trial to compare the live birth rate of the first frozen embryo transfer following the progestin-primed ovarian stimulation protocol vs the antagonist protocol in women with an anticipated high ovarian response","volume":"121","author":"Chen","year":"2024","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2025.114682_b0075","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1156620","article-title":"Comparison of the neonatal outcomes of progestin-primed ovarian stimulation and flexible GnRH antagonist protocols: a propensity score-matched cohort study","volume":"14","author":"Du","year":"2023","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.ejogrb.2025.114682_b0080","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1142\/S2661318224500038","article-title":"Progestin-primed ovarian stimulation versus GnRH antagonist protocol for ovarian stimulation in IVF: a prospective pilot study","volume":"6","author":"Le","year":"2024","journal-title":"Fertil Reprod"},{"key":"10.1016\/j.ejogrb.2025.114682_b0085","doi-asserted-by":"crossref","DOI":"10.4103\/jhrs.jhrs_85_22","article-title":"Comparing progesterone primed ovarian stimulation (PPOS) to GnRH antagonist protocol in oocyte donation cycles","author":"Khurana","year":"2022","journal-title":"J Hum Reprod Sci"},{"key":"10.1016\/j.ejogrb.2025.114682_b0090","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/humrep\/dex367","article-title":"New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF\/ICSI cycles","volume":"33","author":"Yu","year":"2018","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2025.114682_b0095","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.contraception.2021.11.002","article-title":"Contraceptive method preference and reasons for contraceptive discontinuation among women randomized to intramuscular depot medroxyprogesterone acetate, a copper intrauterine device or a levonorgestrel implant: findings from Durban, South Africa","volume":"108","author":"Beesham","year":"2022","journal-title":"Contraception"},{"key":"10.1016\/j.ejogrb.2025.114682_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.jogoh.2020.102030","article-title":"Oral dydrogesterone vs micronized vaginal progesterone gel for luteal phase support in frozen-thawed single blastocyst transfer in good prognosis patients","volume":"50","author":"Ozer","year":"2021","journal-title":"J Gynecol Obstet Hum Reprod"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211525009583?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211525009583?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T14:29:30Z","timestamp":1760365770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211525009583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":21,"alternative-id":["S0301211525009583"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2025.114682","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A retrospective comparison of live birth rate in freeze-all cycles between progestin-primed ovarian stimulation with dydrogesterone and GnRH antagonist protocols","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2025.114682","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114682"}}